Home › Interstitial Lung Diseases › Utah › Salt Lake City
Pag-aaral pangklinika para sa Interstitial Lung Diseases sa Salt Lake City, UT
9 pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Salt Lake City (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Nagre-recruitPhase 3
- University of Utah Health Sciences Center, Salt Lake City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitPhase 3
- USA025, Salt Lake City
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Nagre-recruitPhase 3
- GSK Investigational Site, Salt Lake City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
- University of Utah, Salt Lake City
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Nagre-recruit
- University of Utah, Salt Lake City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitObservasyonal na pag-aaral
- University of Utah Health, Salt Lake City
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Nagre-recruitObservasyonal na pag-aaral
- University of Utah, Salt Lake City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Nagre-recruitPhase 3
- University of Utah Health, Salt Lake City
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Nagre-recruitPhase 2
- aTyr Investigative Site, Salt Lake City
Pag-aaral para sa Interstitial Lung Diseases sa ibang lungsod
- New York City, NY18 pag-aaral
- Philadelphia, PA16 pag-aaral
- Los Angeles, CA14 pag-aaral
- Charleston, SC13 pag-aaral
- Kansas City, KS13 pag-aaral
- Durham, NC13 pag-aaral
- Chicago, IL12 pag-aaral
- Houston, TX12 pag-aaral
- Aurora, CO11 pag-aaral
- Ann Arbor, MI11 pag-aaral
- Dallas, TX9 pag-aaral
- Boston, MA9 pag-aaral
Iba pang pag-aaral sa Salt Lake City
- Non-Small Cell Lung Cancer31 pag-aaral
- Kanser (lahat ng uri)27 pag-aaral
- Kanser sa Suso27 pag-aaral
- Colorectal Cancer22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Melanoma21 pag-aaral
- Multiple Myeloma21 pag-aaral
- Metastatic Cancer20 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Obesity18 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Pagkabigo ng Puso17 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.